Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FDAFQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,815
Award facts
- Contract value 100% obligated
- $60,815.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $60.8K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Cimzia 2x200 mg/ml syringe kits. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999.9 million through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly through the DLA, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent IDC with DLA represents a flexible contracting vehicle that enables AmerisourceBergen to supply pharmaceutical products to various government customers including the Defense Health Agency and U.S. Coast Guard, with the DLA currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts across multiple regions.
Quick answers
Who was awarded contract SPE2DB25FDAFQ?
SPE2DB25FDAFQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FDAFQ worth?
The government has obligated $60,815 on SPE2DB25FDAFQ.
Is contract SPE2DB25FDAFQ an order under another contract?
Yes. SPE2DB25FDAFQ is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAFQ competed?
The extent of competition for SPE2DB25FDAFQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award